Analyzing Mid-to-Long Term Mortality Rates and Associated Factors of Geriatric Patients with Hip Fractures during the COVID-19 Pandemic: A Single Centre Prospective Study

Abstract

Objective
 Our objective was to evaluate the mid-to-long term mortality rates (with an average of 1-year follow-up) and associated factors of geriatric patients with hip fractures during the COVID-19 pandemic.
 Methods
 Prospectively followed-up 104 geriatric patients over 65 years old, with hip fractures during the pandemic, 89 of which underwent surgery, were evaluated. A control group of 126 geriatric patients treated for hip fractures before the pandemic was formed. Patient demographics, initial SARS-Cov-2 Reverse Transcriptase PCR test results, fracture type, type of surgery performed, length of stay (LOS) in hospital early complications were analyzed. 
 Results
 Mid-to-long term mortality rate of geriatric patients with hip fractures treated during the pandemic period was 42.3% whereas the mortality rate of control group was calculated as 38.9% (p=0.599). Patients that were unfit for surgery and patients with positive initial SARS-Cov-2 Reverse Transcriptase PCR test were significantly related with higher mortality (p